Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 1999

View Archived Issues

New mediator of allergic asthma revealed in studies using interleukin-13 fusion protein

AMPA antagonists and their use described by Pfizer

Tricyclic antiproliferative agents revealed by Schering-Plough

Cancer Research Campaign Technology evaluates new antitumor trimelamol analogues

New broad-spectrum antibacterial series patented by Bayer

Cyanoenamines as potassium channel modulators

Roche presents new compound for hyperproliferative skin disorders

Licensing opportunity announced: liposomal compound for treatment of ARDS

AstraZeneca merger proceedings under way

New indication approved for Livial, a tissue-specific treatment for menopausal symptoms

Results from large study comparing atovaquone and dapsone for PCP prophylaxis published

Different concentrations of olopatadine compared to placebo for preventing allergic conjunctivitis

Z-335 characterized as potent, orally effective and long-acting antiplatelet/antithrombotic agent

Targeted Genetics, Sangamo combine two novel technologies for drug discovery

La Jolla reports progress on three fronts at H&Q conference

InKine investigates Syk kinase inhibitors for asthma, other inflammatory conditions

Watson completes TheraTech acquisition

Knoll's antiobesity drug Reductil approved in Germany

Relationship between antitumor activity of bombesin/GRP antagonists and effects on EGF receptors

Antiidiotype MAb in development by Immune Network Research receives patent coverage

Besins Iscovesco provides funds to speed development of Andractim

LeukoSite, Warner-Lambert collaborate on integrin antagonist research

Takeda submits NDA for type II diabetes treatment

Dose of O6-benzylguanine for use with BCNU in brain cancer patients determined

Cell Pathways explores SAANDs as new class of anticancer drugs; patent issues in U.S.

Allelix: Q1 1999 highlights

Oral heparin shown equivalent in efficacy and safety to injectable heparin

New neurological and immunological therapies basis of Neurocrine Biosciences-Caliper collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...